Transcriptomics

Dataset Information

0

The lysine demethylase LSD1 controls the balance between inflammatory and antiviral responses against coronaviruses


ABSTRACT: Innate responses to coronavirus are highly cell-specific and remain to date incompletely understood. Tissue-resident macrophages, which are infected by SARS-CoV2 in patients but inconsistently in vitro, exert critical but conflicting effects by secreting both anti-viral type I Interferons and tissue-damaging inflammatory cytokines. Steroids, the only class of host-targeting drugs approved for Covid19, indiscriminately suppress both responses, possibly impairing viral clearance. Here we set up in vitro culture systems with the prototypical murine coronavirus MHV that allow to separately investigate cell-intrinsic and -extrinsic proinflammatory and antiviral activities. We then studied the role of the lysine-demethylase LSD1, previously implicated in innate responses in cancer. We show that the NF-κB-dependent inflammatory response is selectively inhibited by ablating LSD1 with negligible impact on antiviral interferon response. LSD1 ablation additionally unleashed an interferon-independent antiviral response and blocked viral egress through the lysosomal pathway. A cell-intrinsic antiviral and anti-inflammatory activity of LSD1 inhibition was confirmed on in vitro and a recently developed aerosolized in vivo model of human SARS-COV2 infection. These results show that LSD1 controls innate responses against coronaviruses at multiple levels and provide a mechanistic rationale for repurposing LSD1 inhibitors, a class of drugs extensively studied in oncology, for Covid-19 treatment.

ORGANISM(S): Mus musculus

PROVIDER: GSE169399 | GEO | 2023/06/24

REPOSITORIES: GEO

Similar Datasets

2022-07-22 | GSE209550 | GEO
2023-01-02 | E-MTAB-11781 | biostudies-arrayexpress
2023-07-12 | GSE208116 | GEO
2010-06-05 | E-GEOD-546 | biostudies-arrayexpress
2023-09-28 | GSE234486 | GEO
2021-01-04 | PXD021494 | Pride
2014-08-31 | E-GEOD-56677 | biostudies-arrayexpress
2020-06-19 | GSE150392 | GEO
2022-03-01 | GSE193555 | GEO
2021-11-03 | PXD026216 | Pride